Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1644
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Bevacizumab combined with chemotherapy in the treatment of recurrence or platinum-refractory ovarian cancer: A retrospective study of 37 cases

Li Y, Yang Y, Shang Y M, Zheng H

Year : 2014| Volume: 51| Issue : 7 | Page no: 92-94

   This article has been cited by
1 Bevacizumab improves overall survival in platinum refractory ovarian cancer patients: A retrospective study
Kenro Chikazawa,Sachiho Netsu,Tomoyuki Kuwata,Ryo Konno
Taiwanese Journal of Obstetrics and Gynecology. 2018; 57(6): 819
[Pubmed]  [Google Scholar] [DOI]
2 TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer
Meiying Zhang,Guanglei Zhuang,Xiangjun Sun,Yanying Shen,Wenjing Wang,Qing Li,Wen Di
Diagnostic Pathology. 2017; 12(1)
[Pubmed]  [Google Scholar] [DOI]


  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow